Invested in Powerhouse Biology (precision peptide therapeutics for mitochondrial dysfunction) as part of Fund II portfolio.
Transformative technology to orchestrate cellular energy production in human cells, addressing mitochondrial dysfunction, particularly as we age
Transformative technology to orchestrate cellular energy production in human cells, addressing mitochondrial dysfunction, particularly as we age.